BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9407954)

  • 1. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.
    Petrukhin L; Dangel J; Vanderveer L; Costalas J; Bellacosa A; Grana G; Daly M; Godwin AK
    Cancer Res; 1997 Dec; 57(24):5480-4. PubMed ID: 9407954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
    Berman DB; Costalas J; Schultz DC; Grana G; Daly M; Godwin AK
    Cancer Res; 1996 Aug; 56(15):3409-14. PubMed ID: 8758903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews.
    Abrahamson J; Moslehi R; Vesprini D; Karlan B; Fishman D; Smotkin D; Ben David Y; Biran H; Fields A; Brunet JS; Narod SA
    Cancer Res; 1998 Jul; 58(14):2919-22. PubMed ID: 9679945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
    Neuhausen S; Gilewski T; Norton L; Tran T; McGuire P; Swensen J; Hampel H; Borgen P; Brown K; Skolnick M; Shattuck-Eidens D; Jhanwar S; Goldgar D; Offit K
    Nat Genet; 1996 May; 13(1):126-8. PubMed ID: 8673092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features.
    Locker GY; Kaul K; Weinberg DS; Gatalica Z; Gong G; Peterman A; Lynch J; Klatzco L; Olopade OI; Bomzer CA; Newlin A; Keenan E; Tajuddin M; Knezetic J; Coronel S; Lynch HT
    Cancer Genet Cytogenet; 2006 Aug; 169(1):33-8. PubMed ID: 16875934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
    Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
    Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms.
    Zauber NP; Sabbath-Solitare M; Marotta S; Zauber AG; Foulkes W; Chan M; Turner F; Bishop DT
    Cancer; 2005 Aug; 104(4):719-29. PubMed ID: 15959913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
    Oddoux C; Struewing JP; Clayton CM; Neuhausen S; Brody LC; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K
    Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
    Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
    Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
    Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer.
    Lothe RA; Hektoen M; Johnsen H; Meling GI; Andersen TI; Rognum TO; Lindblom A; Børresen-Dale AL
    Cancer Res; 1998 Jul; 58(14):2923-4. PubMed ID: 9679946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.
    Schorge JO; Mahoney NM; Miller DS; Coleman RL; Muller CY; Euhus DM; Tomlinson GE
    Gynecol Oncol; 2001 Nov; 83(2):383-7. PubMed ID: 11606101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.
    Tobias DH; Eng C; McCurdy LD; Kalir T; Mandelli J; Dottino PR; Cohen CJ
    Gynecol Oncol; 2000 Aug; 78(2):148-51. PubMed ID: 10926794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
    Stadler ZK; Saloustros E; Hansen NA; Schluger AE; Kauff ND; Offit K; Robson ME
    Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers.
    Gershoni-Baruch R; Patael Y; Dagan ; Figer A; Kasinetz L; Kadouri E; Bruchim Bar Sade R; Friedman E
    Br J Cancer; 2000 Jul; 83(2):153-5. PubMed ID: 10901363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.
    Struewing JP; Abeliovich D; Peretz T; Avishai N; Kaback MM; Collins FS; Brody LC
    Nat Genet; 1995 Oct; 11(2):198-200. PubMed ID: 7550349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of the APC I1307K sequence in Jewish and non-Jewish patients with inflammatory bowel disease.
    Yin J; Harpaz N; Souza RF; Zou T; Kong D; Wang S; Leytin AL; Medalie NS; Smolinski KN; Abraham JM; Fleisher AS; Meltzer SJ
    Oncogene; 1999 Jul; 18(26):3902-4. PubMed ID: 10445854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
    Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.